216 related articles for article (PubMed ID: 25872148)
1. Validation of the Ion Torrent PGM sequencing for the prospective routine molecular diagnostic of colorectal cancer.
Belardinilli F; Capalbo C; Buffone A; Petroni M; Colicchia V; Ferraro S; Zani M; Nicolussi A; D'Inzeo S; Coppa A; Screpanti I; Gulino A; Giannini G
Clin Biochem; 2015 Sep; 48(13-14):908-10. PubMed ID: 25872148
[TBL] [Abstract][Full Text] [Related]
2. Ion Torrent next-generation sequencing for routine identification of clinically relevant mutations in colorectal cancer patients.
Malapelle U; Vigliar E; Sgariglia R; Bellevicine C; Colarossi L; Vitale D; Pallante P; Troncone G
J Clin Pathol; 2015 Jan; 68(1):64-8. PubMed ID: 25378536
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of different massive parallel sequencing platforms for mutation profiling in formalin-fixed and paraffin-embedded samples].
Jiang RR; Wang YJ; Teng XD; Xiao L; Bu H; Ye F
Zhonghua Bing Li Xue Za Zhi; 2018 Aug; 47(8):591-596. PubMed ID: 30107663
[No Abstract] [Full Text] [Related]
4. Validation of targeted next-generation sequencing for RAS mutation detection in FFPE colorectal cancer tissues: comparison with Sanger sequencing and ARMS-Scorpion real-time PCR.
Gao J; Wu H; Wang L; Zhang H; Duan H; Lu J; Liang Z
BMJ Open; 2016 Jan; 6(1):e009532. PubMed ID: 26747035
[TBL] [Abstract][Full Text] [Related]
5. Validation of an Ion Torrent Sequencing Platform for the Detection of Gene Mutations in Biopsy Specimens from Patients with Non-Small-Cell Lung Cancer.
Fujita S; Masago K; Takeshita J; Okuda C; Otsuka K; Hata A; Kaji R; Katakami N; Hirata Y
PLoS One; 2015; 10(6):e0130219. PubMed ID: 26076009
[TBL] [Abstract][Full Text] [Related]
6. Detection of variations and identifying genomic breakpoints for large deletions in the LDLR by Ion Torrent semiconductor sequencing.
Faiz F; Allcock RJ; Hooper AJ; van Bockxmeer FM
Atherosclerosis; 2013 Oct; 230(2):249-55. PubMed ID: 24075752
[TBL] [Abstract][Full Text] [Related]
7. The utility of the Ion Torrent PGM next generation sequencing for analysis of the most commonly mutated genes among patients with colorectal cancer in India.
Mehra S; Tiwari AK; Mehta SP; Sachdev R; Rajvanshi C; Chauhan R; Saini A; Vaid A
Indian J Cancer; 2022; 59(2):218-222. PubMed ID: 33753628
[TBL] [Abstract][Full Text] [Related]
8. [Screening for genetic mutations in hyperphenylalaninemia using Ion Torrent PGM sequencing].
Cao Y; Qu Y; Song F; Bai J; Jin Y; Wang H
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2015 Feb; 32(1):16-20. PubMed ID: 25636092
[TBL] [Abstract][Full Text] [Related]
9. Clinical validation of the next-generation sequencing-based Extended RAS Panel assay using metastatic colorectal cancer patient samples from the phase 3 PRIME study.
Udar N; Lofton-Day C; Dong J; Vavrek D; Jung AS; Meier K; Iyer A; Slaughter R; Gutekunst K; Bach BA; Peeters M; Douillard JY
J Cancer Res Clin Oncol; 2018 Oct; 144(10):2001-2010. PubMed ID: 30019318
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Ion Personal Genome Machine Platforms for the Detection of Variants in
Hwang SM; Lee KC; Lee MS; Park KU
Cancer Res Treat; 2018 Jan; 50(1):255-264. PubMed ID: 28392550
[TBL] [Abstract][Full Text] [Related]
11. Fast clinical molecular diagnosis of hyperphenylalaninemia using next-generation sequencing-based on a custom AmpliSeq™ panel and Ion Torrent PGM sequencing.
Cao YY; Qu YJ; Song F; Zhang T; Bai JL; Jin YW; Wang H
Mol Genet Metab; 2014 Dec; 113(4):261-6. PubMed ID: 25456745
[TBL] [Abstract][Full Text] [Related]
12. The Italian external quality assessment for RAS testing in colorectal carcinoma identifies methods-related inter-laboratory differences.
Normanno N; Pinto C; Castiglione F; Fenizia F; Barberis M; Marchetti A; Fontanini G; De Rosa G; Taddei GL
J Transl Med; 2015 Sep; 13():287. PubMed ID: 26335936
[TBL] [Abstract][Full Text] [Related]
13. Development of pyrosequencing methods for the rapid detection of RAS mutations in clinical samples.
Cortes U; Guilloteau K; Rouvreau M; Archaimbault C; Villalva C; Karayan-Tapon L
Exp Mol Pathol; 2015 Oct; 99(2):207-11. PubMed ID: 26163758
[TBL] [Abstract][Full Text] [Related]
14. Molecular diagnostics of the HBB gene in an Omani cohort using bench-top DNA Ion Torrent PGM technology.
Hassan SM; Vossen RH; Chessa R; den Dunnen JT; Bakker E; Giordano PC; Harteveld CL
Blood Cells Mol Dis; 2014 Sep; 53(3):133-7. PubMed ID: 24880717
[TBL] [Abstract][Full Text] [Related]
15. Extended RAS and BRAF Mutation Analysis Using Next-Generation Sequencing.
Sakai K; Tsurutani J; Yamanaka T; Yoneshige A; Ito A; Togashi Y; De Velasco MA; Terashima M; Fujita Y; Tomida S; Tamura T; Nakagawa K; Nishio K
PLoS One; 2015; 10(5):e0121891. PubMed ID: 25954997
[TBL] [Abstract][Full Text] [Related]
16. Versatile ion S5XL sequencer for targeted next generation sequencing of solid tumors in a clinical laboratory.
Mehrotra M; Duose DY; Singh RR; Barkoh BA; Manekia J; Harmon MA; Patel KP; Routbort MJ; Medeiros LJ; Wistuba II; Luthra R
PLoS One; 2017; 12(8):e0181968. PubMed ID: 28767674
[TBL] [Abstract][Full Text] [Related]
17. Rare RAS Mutations in Metastatic Colorectal Cancer Detected During Routine RAS Genotyping Using Next Generation Sequencing.
Harlé A; Filhine-Tresarrieu P; Husson M; Boidot R; Rouyer M; Dubois C; Leroux A; Merlin JL
Target Oncol; 2016 Jun; 11(3):363-70. PubMed ID: 26661077
[TBL] [Abstract][Full Text] [Related]
18. High-throughput screening of extended RAS mutations based on high-resolution melting analysis for prediction of anti-EGFR treatment efficacy in colorectal carcinoma.
Ishige T; Itoga S; Sato K; Kitamura K; Nishimura M; Sawai S; Matsushita K; Suzuki K; Ota S; Miyauchi H; Matsubara H; Nakatani Y; Nomura F
Clin Biochem; 2014 Dec; 47(18):340-3. PubMed ID: 25262986
[TBL] [Abstract][Full Text] [Related]
19. Clinical validation of a next-generation sequencing screen for mutational hotspots in 46 cancer-related genes.
Singh RR; Patel KP; Routbort MJ; Reddy NG; Barkoh BA; Handal B; Kanagal-Shamanna R; Greaves WO; Medeiros LJ; Aldape KD; Luthra R
J Mol Diagn; 2013 Sep; 15(5):607-22. PubMed ID: 23810757
[TBL] [Abstract][Full Text] [Related]
20. Performance validation of an amplicon-based targeted next-generation sequencing assay and mutation profiling of 648 Chinese colorectal cancer patients.
Wang Y; Liu H; Hou Y; Zhou X; Liang L; Zhang Z; Shi H; Xu S; Hu P; Zheng Z; Liu R; Tang T; Ye F; Liang Z; Bu H
Virchows Arch; 2018 Jun; 472(6):959-968. PubMed ID: 29705968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]